BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37953084)

  • 1. Impact of COVID-19 on Pharmacy Education and Practice: Strategies to Boost Advocacy and Unity among Health Care Organizations.
    Kahaleh AA; Ellington TM; Coker AO; Tillery E; Manasco KB; Truong HA; Kebodeaux CD; Edwards KL; Hayatshahi A; Gumina G; Hughes JA; Fuentes DG
    Am J Pharm Educ; 2023 Dec; 87(12):100091. PubMed ID: 37953084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacy Emergency Preparedness and Response (PEPR): a proposed framework for expanding pharmacy professionals' roles and contributions to emergency preparedness and response during the COVID-19 pandemic and beyond.
    Aruru M; Truong HA; Clark S
    Res Social Adm Pharm; 2021 Jan; 17(1):1967-1977. PubMed ID: 32389631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Never waste a good crisis": Opportunities and constraints from the COVID-19 pandemic on pharmacists' scope of practice.
    Chiu K; Thow AM; Bero L
    Res Social Adm Pharm; 2022 Sep; 18(9):3638-3648. PubMed ID: 35414485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the COVID-19 Pandemic on the Community Pharmacy Workforce.
    Bacci JL; Pollack SW; Skillman SM; Odegard PS; Danielson JH; Frogner BK
    Med Care Res Rev; 2024 Feb; 81(1):39-48. PubMed ID: 37830446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacists' readiness to deal with the coronavirus pandemic: Assessing awareness and perception of roles.
    Basheti IA; Nassar R; Barakat M; Alqudah R; Abufarha R; Mukattash TL; Saini B
    Res Social Adm Pharm; 2021 Mar; 17(3):514-522. PubMed ID: 32360181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing Community Pharmacists' Perception on Readiness to Initiate Point-of-Care Testing for SARS-CoV-2 in New York State During the Pandemic.
    Ngwu RO; Lindeau R; Bielecki LM; Daly CJ
    J Pharm Pract; 2024 Apr; 37(2):324-334. PubMed ID: 36242519
    [No Abstract]   [Full Text] [Related]  

  • 7. How COVID-19 has impacted the role of pharmacists around the world.
    Jordan D; Guiu-Segura JM; Sousa-Pinto G; Wang LN
    Farm Hosp; 2021 Feb; 45(2):89-95. PubMed ID: 33709893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacists' expectations for entry-level practitioner competency.
    Boyle M; Myford C
    Am J Pharm Educ; 2013 Feb; 77(1):5. PubMed ID: 23459441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Public perceptions about pharmacists' role in prescribing, providing education and delivering medications during COVID-19 pandemic era.
    Alhamad H; Abu-Farha R; Albahar F; Jaber D
    Int J Clin Pract; 2021 Apr; 75(4):e13890. PubMed ID: 33280210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishing clinical pharmacist telehealth services during the COVID-19 pandemic.
    Segal EM; Alwan L; Pitney C; Taketa C; Indorf A; Held L; Lee KS; Son M; Chi M; Diamantides E; Gosser R
    Am J Health Syst Pharm; 2020 Aug; 77(17):1403-1408. PubMed ID: 34279578
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Patterson SM; Cadogan CA; Barry HE; Hughes CM
    BMJ Open; 2022 Sep; 12(9):e064549. PubMed ID: 36137632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Jersey Pharmacists' Perceptions on Performing COVID-19 Testing in Community Pharmacy Practice Sites.
    Brust-Sisti LA; Armanious ME; Ohlinger K; Patel J; Lodhia T; Sturgill MG; Volino LR
    J Pharm Pract; 2023 Aug; 36(4):853-860. PubMed ID: 35357961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Provision of community pharmacy services during COVID-19 pandemic: a cross sectional study of community pharmacists' experiences with preventative measures and sources of information.
    Hoti K; Jakupi A; Hetemi D; Raka D; Hughes J; Desselle S
    Int J Clin Pharm; 2020 Aug; 42(4):1197-1206. PubMed ID: 32524513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacists' Preparedness to Patients Education at the Time of Pandemic-A Cross-Sectional Study with an Example of SARS-CoV-2 Outbreak in Poland.
    Cerbin-Koczorowska M; Waszyk-Nowaczyk M; Przymuszała P
    Int J Environ Res Public Health; 2020 Sep; 17(18):. PubMed ID: 32932684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enablers and challenges to pharmacy practice change in Kuwait hospitals: a qualitative exploration of pharmacists' perceptions.
    Katoue MG
    J Eval Clin Pract; 2021 Apr; 27(2):272-279. PubMed ID: 32929812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the frontline against COVID-19: Community pharmacists' contribution during a public health crisis.
    Cadogan CA; Hughes CM
    Res Social Adm Pharm; 2021 Jan; 17(1):2032-2035. PubMed ID: 32245691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Provision of clinical pharmacy services during the COVID-19 pandemic: Experiences of pharmacists from 16 European countries.
    Paudyal V; Cadogan C; Fialová D; Henman MC; Hazen A; Okuyan B; Lutters M; Stewart D
    Res Social Adm Pharm; 2021 Aug; 17(8):1507-1517. PubMed ID: 33288420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical care tele-pharmacy services during COVID-19 pandemic: A qualitative exploration of healthcare practitioners' perceptions.
    Isleem N; Shoshaa S; AbuGhalyoun A; Khatib M; Naseralallah LM; Ibn-Mas'ud Danjuma M; Saad M
    J Clin Pharm Ther; 2022 Oct; 47(10):1591-1599. PubMed ID: 35699243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic.
    Cochran G; Bruneau J; Cox N; Gordon AJ
    Subst Abus; 2020; 41(3):269-274. PubMed ID: 32697171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The coping strategies of community pharmacists and pharmaceutical services provided during COVID-19 in Malaysia.
    Kua KP; Lee SWH
    Int J Clin Pract; 2021 Dec; 75(12):e14992. PubMed ID: 34710264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.